Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
64
PRAX Quote, Financials, Valuation and Earnings
Last price:
$313.08
Seasonality move
:
-41.81%
Day range:
$294.29 - $305.68
52-week range:
$26.70 - $317.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
842.67x
P/B ratio:
21.68x
Volume:
785.9K
Avg. volume:
757.8K
1-year change:
327.85%
Market cap:
$7.4B
Revenue:
$8.6M
EPS (TTM):
-$12.90
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $2.4M | $8.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 249.53% | |
| Cost of Revenues | $746K | $1.6M | $1.2M | $432K | $358K | |
| Gross Profit | -$746K | -$1.6M | -$1.2M | $2M | $8.2M | |
| Gross Profit Margin | -- | -- | -- | 82.35% | 95.81% | |
| R&D Expenses | $45M | $120.3M | $155M | $86.8M | $152.4M | |
| Selling, General & Admin | $17M | $47.1M | $59.9M | $42.1M | $56.3M | |
| Other Inc / (Exp) | $140K | $271K | $957K | $3.1M | $17.3M | |
| Operating Expenses | $61.2M | $165.7M | $213.8M | $128.4M | $208.4M | |
| Operating Income | -$62M | -$167.3M | -$215M | -$126.4M | -$200.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$61.8M | -$167.1M | -$214M | -$123.3M | -$182.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$8K | -- | -- | -- | -- | |
| Net Income to Company | -$61.8M | -$167.1M | -$214M | -$123.3M | -$182.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$61.3M | -$167.1M | -$214M | -$123.3M | -$182.8M | |
| Basic EPS (Cont. Ops) | -$27.56 | -$59.03 | -$69.65 | -$18.69 | -$10.21 | |
| Diluted EPS (Cont. Ops) | -$27.56 | -$59.03 | -$69.65 | -$18.69 | -$10.21 | |
| Weighted Average Basic Share | $2.6M | $2.8M | $3.1M | $6.6M | $17.9M | |
| Weighted Average Diluted Share | $2.6M | $2.8M | $3.1M | $6.6M | $17.9M | |
| EBITDA | -$61.2M | -$165.7M | -$213.8M | -$125.9M | -$199.8M | |
| EBIT | -$62M | -$167.3M | -$215M | -$126.4M | -$200.2M | |
| Revenue (Reported) | -- | -- | -- | $2.4M | $8.6M | |
| Operating Income (Reported) | -$62M | -$167.3M | -$215M | -$126.4M | -$200.2M | |
| Operating Income (Adjusted) | -$62M | -$167.3M | -$215M | -$126.4M | -$200.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $468K | $302K | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -35.47% | -100% | |
| Cost of Revenues | $506K | $292K | $321K | $92K | $19K | |
| Gross Profit | -$506K | -$292K | $147K | $210K | -$19K | |
| Gross Profit Margin | -- | -- | 31.41% | 69.54% | -- | |
| R&D Expenses | $33.1M | $30.4M | $17.3M | $41.9M | $65.8M | |
| Selling, General & Admin | $11.6M | $13.9M | $8.7M | $15.3M | $12.6M | |
| Other Inc / (Exp) | $73K | $345K | $884K | $4.9M | -- | |
| Operating Expenses | $44.3M | $44M | $25.7M | $57M | $78.3M | |
| Operating Income | -$44.8M | -$44.3M | -$25.5M | -$56.8M | -$78.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$44.7M | -$43.9M | -$24.6M | -$51.9M | -$73.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5K | -- | -- | -- | -- | |
| Net Income to Company | -$44.7M | -$43.9M | -$24.6M | -$51.9M | -$73.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$44.7M | -$43.9M | -$24.6M | -$51.9M | -$73.9M | |
| Basic EPS (Cont. Ops) | -$15.00 | -$14.40 | -$2.72 | -$2.75 | -$3.36 | |
| Diluted EPS (Cont. Ops) | -$15.00 | -$14.40 | -$2.72 | -$2.75 | -$3.36 | |
| Weighted Average Basic Share | $3M | $3.1M | $9M | $18.9M | $22M | |
| Weighted Average Diluted Share | $3M | $3.1M | $9M | $18.9M | $22M | |
| EBITDA | -$44.3M | -$44M | -$25.2M | -$56.7M | -$78.3M | |
| EBIT | -$44.8M | -$44.3M | -$25.5M | -$56.8M | -$78.4M | |
| Revenue (Reported) | -- | -- | $468K | $302K | -- | |
| Operating Income (Reported) | -$44.8M | -$44.3M | -$25.5M | -$56.8M | -$78.4M | |
| Operating Income (Adjusted) | -$44.8M | -$44.3M | -$25.5M | -$56.8M | -$78.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.9M | $1.6M | $7.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2M | $1.4M | $1.2M | $422K | $159K | |
| Gross Profit | -$1.2M | -$1.4M | $691K | $1.2M | $7.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $93M | $170.2M | $96.7M | $114.5M | $245.9M | |
| Selling, General & Admin | $41.4M | $62M | $45.2M | $51.1M | $54.7M | |
| Other Inc / (Exp) | $207K | $747K | $2.4M | $13M | -- | |
| Operating Expenses | $133.2M | $230.8M | $140.7M | $165.2M | $300.4M | |
| Operating Income | -$134.4M | -$232.2M | -$140M | -$164M | -$293.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$134.2M | -$231.4M | -$137.6M | -$151M | -$273M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5K | -$5K | -- | -- | -- | |
| Net Income to Company | -$134.2M | -$231.4M | -$137.6M | -$151M | -$273M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$134.2M | -$231.4M | -$137.6M | -$151M | -$273M | |
| Basic EPS (Cont. Ops) | -$49.25 | -$76.45 | -$33.66 | -$10.30 | -$12.90 | |
| Diluted EPS (Cont. Ops) | -$49.25 | -$76.45 | -$33.66 | -$10.30 | -$12.90 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$133.2M | -$230.8M | -$138.8M | -$163.6M | -$293M | |
| EBIT | -$134.4M | -$232.2M | -$140M | -$164M | -$293.1M | |
| Revenue (Reported) | -- | -- | $1.9M | $1.6M | $7.5M | |
| Operating Income (Reported) | -$134.4M | -$232.2M | -$140M | -$164M | -$293.1M | |
| Operating Income (Adjusted) | -$134.4M | -$232.2M | -$140M | -$164M | -$293.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.9M | $1.1M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1M | $870K | $940K | $311K | $112K | |
| Gross Profit | -$1M | -$870K | $992K | $779K | -$112K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $76.7M | $126.7M | $68.4M | $96.1M | $189.6M | |
| Selling, General & Admin | $31.9M | $46.8M | $32.1M | $41.2M | $39.5M | |
| Other Inc / (Exp) | $201K | $677K | $2.2M | $12.1M | $10.4M | |
| Operating Expenses | $107.6M | $172.7M | $99.6M | $137M | $229M | |
| Operating Income | -$108.7M | -$173.5M | -$98.6M | -$136.2M | -$229.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$108.5M | -$172.9M | -$96.4M | -$124.1M | -$214.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5K | -- | -- | -- | -- | |
| Net Income to Company | -$108.5M | -$172.9M | -$96.4M | -$124.1M | -$214.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$108.5M | -$172.9M | -$96.4M | -$124.1M | -$214.4M | |
| Basic EPS (Cont. Ops) | -$38.80 | -$56.90 | -$20.68 | -$7.33 | -$9.97 | |
| Diluted EPS (Cont. Ops) | -$38.80 | -$56.90 | -$20.68 | -$7.33 | -$9.97 | |
| Weighted Average Basic Share | $8.3M | $9.1M | $17.2M | $51.6M | $64.5M | |
| Weighted Average Diluted Share | $8.3M | $9.1M | $17.2M | $51.6M | $64.5M | |
| EBITDA | -$107.6M | -$172.7M | -$97.6M | -$135.9M | -$229M | |
| EBIT | -$108.7M | -$173.5M | -$98.6M | -$136.2M | -$229.2M | |
| Revenue (Reported) | -- | -- | $1.9M | $1.1M | -- | |
| Operating Income (Reported) | -$108.7M | -$173.5M | -$98.6M | -$136.2M | -$229.2M | |
| Operating Income (Adjusted) | -$108.7M | -$173.5M | -$98.6M | -$136.2M | -$229.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $297.2M | $275.9M | $100.5M | $81.3M | $392.6M | |
| Short Term Investments | -- | $137.2M | $38.9M | -- | $177.2M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.7M | $11.5M | $10.4M | $3.6M | $11.8M | |
| Total Current Assets | $302.3M | $287.4M | $110.8M | $84.9M | $404.4M | |
| Property Plant And Equipment | $836K | $4.9M | $3.9M | $2.7M | $1.4M | |
| Long-Term Investments | -- | -- | $416K | $416K | $77.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $15K | $472K | $416K | $416K | $416K | |
| Total Assets | $303.2M | $292.7M | $115.1M | $87.9M | $483.1M | |
| Accounts Payable | $4.1M | $10.8M | $14.7M | $5.8M | $12.5M | |
| Accrued Expenses | $5.4M | $19.7M | $13M | $3.7M | $14.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $763K | $810K | $1M | $1.1M | $1.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $15.7M | $38.4M | $34.3M | $15.7M | $37.6M | |
| Long-Term Debt | -- | $3.5M | $2.5M | $1.4M | $110K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $15.7M | $41.9M | $39M | $18.3M | $37.7M | |
| Common Stock | $4K | $5K | $5K | $13K | $14K | |
| Other Common Equity Adj | -- | -$176K | -$173K | -- | $654K | |
| Common Equity | $287.5M | $250.8M | $76.1M | $69.7M | $445.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $287.5M | $250.8M | $76.1M | $69.7M | $445.5M | |
| Total Liabilities and Equity | $303.2M | $292.7M | $115.1M | $87.9M | $483.1M | |
| Cash and Short Terms | $297.2M | $275.9M | $100.5M | $81.3M | $392.6M | |
| Total Debt | -- | $3.5M | $2.5M | $1.4M | $110K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $315M | $123.7M | $101.1M | $357M | $267.2M | |
| Short Term Investments | $148.7M | $61.3M | -- | $188.4M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5M | $8.6M | $2.2M | $3M | -- | |
| Total Current Assets | $319.3M | $132.3M | $103.3M | $360M | $273.8M | |
| Property Plant And Equipment | $4.7M | $4.2M | $3M | $1.7M | $536K | |
| Long-Term Investments | $400K | $416K | $416K | $54.6M | $122M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $416K | $416K | $416K | $416K | -- | |
| Total Assets | $324.4M | $136.9M | $106.7M | $416.3M | $396.4M | |
| Accounts Payable | $7.5M | $10.1M | $7.2M | $15M | $30.8M | |
| Accrued Expenses | $12.6M | $15.2M | $5M | $12.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $681K | $977K | $1.1M | $1.2M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $24.8M | $29M | $16.8M | $32.9M | $52.9M | |
| Long-Term Debt | $3.7M | $2.8M | $1.7M | $436K | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $28.5M | $31.7M | $20M | $33.6M | $52.9M | |
| Common Stock | $5K | $5K | $13K | $14K | $14K | |
| Other Common Equity Adj | -$25K | -$536K | -- | $1.3M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $295.9M | $105.2M | $86.8M | $382.7M | $343.5M | |
| Total Liabilities and Equity | $324.4M | $136.9M | $106.7M | $416.3M | $396.4M | |
| Cash and Short Terms | $315M | $123.7M | $101.1M | $357M | $267.2M | |
| Total Debt | $3.7M | $2.8M | $1.7M | $436K | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$61.8M | -$167.1M | -$214M | -$123.3M | -$182.8M | |
| Depreciation & Amoritzation | $50K | $182K | $419K | $432K | $358K | |
| Stock-Based Compensation | $5.2M | $22.7M | $28.6M | $24.9M | $41.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$51.9M | -$123.8M | -$184.2M | -$110.1M | -$131.8M | |
| Capital Expenditures | -- | $1.1M | $444K | $50K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$140.5M | $96.9M | $39M | -$248.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $30M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$575K | -$522K | -$137K | -$308K | |
| Cash From Financing | $303.7M | $106.8M | $9.7M | $90.9M | $514.3M | |
| Beginning Cash (CF) | $297.2M | $138.7M | $61.6M | $81.3M | $215.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $251.8M | -$157.5M | -$77.7M | $19.7M | $134.1M | |
| Ending Cash (CF) | $549M | -$18.8M | -$16.1M | $101M | $349.4M | |
| Levered Free Cash Flow | -$51.9M | -$124.8M | -$184.7M | -$110.2M | -$131.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$44.7M | -$43.9M | -$24.6M | -$51.9M | -$73.9M | |
| Depreciation & Amoritzation | $39K | $102K | $109K | $92K | $19K | |
| Stock-Based Compensation | $6.5M | $6.7M | $5.8M | $12.4M | $7.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$23.8M | -$44.7M | -$23M | -$27.2M | -$64.7M | |
| Capital Expenditures | $450K | $45K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $13.6M | $48M | -- | $49.6M | $50.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$7K | -$1K | -$1K | -- | |
| Cash From Financing | $19K | $3.1M | -$254K | $1.2M | $6.4M | |
| Beginning Cash (CF) | $166.3M | $62.4M | $101.1M | $168.6M | $149.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.2M | $6.4M | -$23.2M | $23.5M | -$7.9M | |
| Ending Cash (CF) | $156.1M | $68.8M | $77.9M | $192.1M | $141.6M | |
| Levered Free Cash Flow | -$24.2M | -$44.7M | -$23M | -$27.2M | -$64.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$134.2M | -$231.4M | -$137.6M | -$151M | -$273M | |
| Depreciation & Amoritzation | $109K | $407K | $426K | $422K | $159K | |
| Stock-Based Compensation | $20.4M | $28.3M | $25.5M | $38.5M | $32.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$99.2M | -$200.3M | -$115.1M | -$98.4M | -$228.8M | |
| Capital Expenditures | $519K | $975K | -- | $50K | $56K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$150.7M | $84.5M | $61.6M | -$237.6M | $6.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $542K | -$515K | -$139K | -$156K | -- | |
| Cash From Financing | $301.2M | $12M | $92.2M | $403.6M | $203.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $51.3M | -$103.8M | $38.6M | $67.6M | -$19.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$99.7M | -$201.3M | -$115.1M | -$98.5M | -$228.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$108.5M | -$172.9M | -$96.4M | -$124.1M | -$214.4M | |
| Depreciation & Amoritzation | $89K | $314K | $321K | $311K | $112K | |
| Stock-Based Compensation | $16.6M | $22.2M | $19.1M | $32.8M | $24M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$79.1M | -$155.7M | -$86.5M | -$74.8M | -$171.8M | |
| Capital Expenditures | $519K | $444K | -- | -- | $56K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$150.7M | $74.3M | $39M | -$237.6M | $17.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$575K | -$515K | -$132K | -$151K | -$1.2M | |
| Cash From Financing | $99.3M | $4.5M | $87M | $399.7M | $88.7M | |
| Beginning Cash (CF) | $474.9M | $196.3M | $306.2M | $465.8M | $472.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$130.5M | -$76.9M | $39.5M | $87.3M | -$65.8M | |
| Ending Cash (CF) | $344.4M | $119.5M | $345.7M | $553.1M | $406.7M | |
| Levered Free Cash Flow | -$79.7M | -$156.1M | -$86.5M | -$74.8M | -$171.9M | |
Get PRAX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PRAX
Sector
P/E ratio
--
23.92x
PEG ratio
-0.91x
-0.01x
P/B ratio
21.68x
1.81x
Price / LTM sales
842.67x
1.60x
Growth Metrics
PRAX
Sector
Revenue growth
-100%
4.35%
Earnings growth
-22.38%
9.8%
Revenue (5-year growth)
--
6.41%
Earnings forecast
-$3.12
-$0.18
Profitability
PRAX
Sector
Profitability FY 2024
$8.2M
$3.3M
Return on invested capital
-67.57%
-32.69%
Return on assets
-61.29%
-29.29%
Return on equity
-67.75%
-38.5%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
4
Balance Sheet
PRAX
Sector
Total cash
$267.2M
$25.6M
Short term investments
$177.2M
$25.1M
Total assets
$483.1M
$75.5M
Long term debt
--
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is down 3.93% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 0.06% over the past day.
Buy
100
TLN alert for Jan 16
Talen Energy Corp. [TLN] is down 11.3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
